Sign in

CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company

Adaptimmune Therapeutics PLC

Sign in to watch
Ticker
ADAPY
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
United Kingdom
Entity type
operating
Phone
44 1235 430000
Business address
60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
Former names
Adaptimmune Ltd
  1. 4 Open-market sale Chief Medical Officer sold 2,111 shares at $5.67 ($11,968)
  2. 4 Open-market sale Chief Patient Supply Officer sold 4,358 shares at $5.67 ($24,708)
  3. 4 Open-market sale Chief Executive Officer sold 9,879 shares at $5.67 ($56,009)
  4. 4 Open-market sale Chief Operating Officer sold 2,234 shares at $6.15 ($13,744)
  5. 4 Open-market sale Chief Patient Supply Officer sold 1,058 shares at $6.15 ($6,509)
  6. 4 Open-market sale Chief Medical Officer sold 841 shares at $6.15 ($5,174)
  7. 4 Open-market sale Chief Executive Officer sold 2,707 shares at $6.15 ($16,654)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market sale Chief Patient Supply Officer sold 1,065 shares at $5.33 ($5,674)
  15. 4 Open-market sale Chief Operating Officer sold 3,499 shares at $5.33 ($18,642)
  16. 4 Open-market sale Chief Medical Officer sold 845 shares at $5.33 ($4,502)
  17. 4 Open-market sale Chief Executive Officer sold 4,967 shares at $5.33 ($26,464)
  18. 4 Open-market buy Chief Financial Officer bought 24,000 shares at $0.69 ($16,550)
  19. 4 Open-market buy Chief Operating Officer bought 207,000 shares at $0.69 ($143,824)
  20. 4 Open-market sale Chief Executive Officer sold 2,776 shares at $8.51 ($23,637)

Page 8 of 18 · 351 filings